Company intelligence / Profile preview

Equus Innovations

Phoenix, Arizona, United States

Ownership: Private
Development stage: Other

Overview

RenoVō has demonstrated safety and efficacy in >2,000 horses for soft tissue and orthopedic injury repair, with multiple prospective field studies including data on lameness improvement and lesion treatment.

Therapeutic areas: RheumatologyOther
Modalities: BiologicAllograft (acellular, liquid allograft from amnion/amniotic fluid)
Industry: Veterinary

Partnerships

Equine Amnio Solutions (US distributor/sister company)Covetrus (exclusive US distributor)

Beyond the preview

Go deeper on Equus Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equus Innovations.

Explore the full profile